Luca Benatti's Insider Trades & SAST Disclosures

Luca Benatti's most recent trade in Quince Therapeutics Inc was a trade of 27,000 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.

Share

Note

This is a custom search result for pattern Luca Benatti.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Quince Therapeutics Inc	Luca Benatti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2025	27,000	27,000	-		-	Director Stock Option (Right to Buy)
Quince Therapeutics Inc	Luca Benatti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	27,000	27,000	-		-	Employee Stock Option (right to buy)
Intercept Pharmaceuticals Inc	Luca Benatti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2023	12,547	12,547	-		-	Option to Purchase Common Stock
Intercept Pharmaceuticals Inc	Luca Benatti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2023	8,111	33,598 (0%)	0%		0	Common Stock
Intercept Pharmaceuticals Inc	Luca Benatti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2022	12,790	12,790	-		-	Option to Purchase Common Stock
Intercept Pharmaceuticals Inc	Luca Benatti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2022	7,737	25,487 (0%)	0%		0	Common Stock
Intercept Pharmaceuticals Inc	Luca Benatti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 May 2021	12,089	12,089	-		-	Option to Purchase Common Stock
Intercept Pharmaceuticals Inc	Luca Benatti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 May 2021	7,029	17,750 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades